Pepti Review: DSIP at $189, and a Price We Can't Confirm

Pepti is a prescription peptide service that actually stocks a sleep peptide: DSIP at $189 a month, and a DSIP, BPC-157 and CJC-1295 blend at $239. Flat monthly pricing, cancel whenever. Almost every seller that advertises sleep is really selling a growth-hormone secretagogue and calling better sleep a side benefit; of seven services we looked at in August 2026, Pepti was the only one carrying DSIP at all.

That is why it has a page here. It does not make it a simple recommendation — its own price data contradicts its advertised price in a way we could not settle, and three things on its shelf have no business being sold to consumers.

The sleep line, and what it is actually worth

DSIP is $189 a month. The blend with BPC-157 and CJC-1295 is $239. Adjacent items: CJC-1295 with ipamorelin at $239, sermorelin at $189, tesamorelin at $189, and epithalon at $209. Pricing is flat per product per month, cancel-anytime with no minimum term, and subscriptions can be paused for up to 90 days.

Before the price matters, the evidence has to. The human DSIP record is a handful of small clinical studies from the 1980s and early 1990s, and it does not read the way the marketing does — the insomnia trials are tiny, the results are mixed, and the peptide's own literature calls it an unresolved question decades on¹². Our DSIP evidence review walks through each study and DSIP dosage covers what those papers actually administered. A seller stocking DSIP is not the same as a seller having something proven to sell, and $189 a month is a real sum to spend against that record.

The same caution applies to the secretagogues beside it. Sermorelin does reliably increase slow-wave sleep in healthy men alongside the expected GH release³, which is why it appears on this site at all — but that is a narrower claim than the category's marketing usually makes. What the sermorelin sleep evidence supports is the version to read before comparing a price.

The pricing problem, stated plainly

Pepti's headline GLP-1 offer is $99 a month for injectable semaglutide and $199 for injectable tirzepatide, flat at every titration dose⁴. Those numbers appear on the product page, on a dedicated cost page, and in the product data the storefront runs on.

The same site also carries a completely different price list, priced by dose — semaglutide at $299 for 0.25 mg, $349 for 0.5 mg, $399 for 1.0 mg and $449 for 2.4 mg; tirzepatide at $349, $399, $449 and $549. No page on the site shows it. It sits behind the storefront, unread, averaging roughly three times the advertised price and contradicting the flat-price promise printed a few inches away.

We could not settle it. The only way to see a real billed amount is to complete a full medical intake and reach a live checkout, and we do not pose as patients (our methodology says why). So we are reporting the conflict instead of smoothing it, and we are not picking a side. We go with the $99, because that is the figure the company publishes and repeats everywhere a customer would look. If you sign up, read the amount on your confirmation screen before you accept it — and read it again the first time your dose goes up.

Why it belongs in a sleep-peptide review: it is evidence about how carefully this operator's published numbers should be read, and the DSIP price came from the same catalog.

Two more places the site disagrees with itself

Where it ships. Four separate surfaces — the shipping page, the state-availability page, the providers page and the homepage title — say 36 states, and publish the list. The terms of service say 50. The 36-state list is corroborated four ways; the terms line is the outlier, and 36 is the number to plan around.

When you are charged. The how-it-works page says you pay nothing until a physician approves your treatment. The refund policy says payment is collected at checkout, before a licensed provider reviews your intake⁵. Same site, opposite claims. The refund policy is the document that governs a dispute, so assume you are charged first. Pepti does state that a provider denial produces a full refund in five to ten business days, and that nothing is refundable once shipped.

What else is on the shelf, including three things that should not be

Pepti lists 68 products, the widest catalog of any service on this site. Recovery peptides (BPC-157 at $209, BPC-157 with TB-500 at $289, KPV at $229, KLOW at $299), NAD+ in three routes ($179 injection, $219 nasal, $159 capsule), GHK-Cu in three formats, MOTS-c, SS-31, epithalon, PT-141, and nasal semax, selank, synapsin and VIP.

It also sells retatrutide, melanotan II and IGF-1 LR3. Retatrutide has no FDA approval in any form or jurisdiction — it is still an investigational molecule in trials. Melanotan II and IGF-1 LR3 are not approvable consumer products. None of the three should be treated as recommendable, and their presence tells you where this operator draws its line. If you compete in a tested sport, note separately that a number of items on that shelf are prohibited in competition.

Who prescribes, and who dispenses

Pepti names two prescribers with full biographies: Dr. Gene Lee, MD, its medical director, board-certified in family medicine and licensed in 26 named states, and Dr. Laeeq Butt, MD MBA, its chief medical officer, internal medicine, licensed in 15 named states. Neither publishes an NPI, so neither could be verified against the national registry — a name and a bio are not a number, and the check needs a number.

The pharmacy is described as "independent FDA-registered 503A or 503B compounding pharmacies" and is never named. The legal address is a well-known registered-agent suite in Newark, Delaware, rather than an operating site.

The regulatory screen

Pepti has no FDA warning letter on record as of August 2026. We searched the agency's index⁶ under the trading name and under the legal entity, and neither appears. The neighborhood is worth knowing about: search the FDA index for "pepti" and you get a long run of letters to research-peptide sellers with similar names. Pepti is not one of them.

A search that comes back empty and a search that is broken look identical, so every screen here includes a company we already know holds a letter. It came back. That is the only reason we are willing to print the clean result — how we check.

The bottom line

If you specifically want DSIP prescribed and shipped rather than sourced gray-market, Pepti is one of very few places to get it, at $189 a month with no lock-in — and the honest framing is that you are paying a real monthly sum against a thin, decades-old evidence base, not that you have found a bargain. Read DSIP benefits and DSIP side effects before that decision, not after. Against the company: no named pharmacy, no verifiable NPI, two self-contradicting policy surfaces, three compounds on the shelf that have no business being sold to consumers, and a per-dose price list in its own data that we could not reconcile with the price it advertises.